Xue Y, Pan Y, Liu Z, Guo Y, Xie X
Jiangsu Institute of Hematology, First Affiliated Hospital of Suzhou Medical College, Suzhou 215006.
Zhonghua Xue Ye Xue Za Zhi. 1997 May;18(5):240-2.
To report two cases of leukemia with t(8;21) and tetraploid clones.
R-banding technique was used.
Cytogenetic studies of BM cells at diagnosis revealed that each of the two cases had three related abnormal clones besides a normal one: 46, XY, t(8;21) (2%), 46, idem, add((7)(q31)(6.8%) and 92, idem x 2 (80.6%) in case 1 and 46, XX, t(8;21) (13.4%), 47, idem, + 4 (46.3%) and 94, idem x 2 (39.1%) in case 2. They did not obtain complete remission on chemotherapy and survived 4 and 6 months, respectively.
Tetraploid or near tetraploid clones are secondary events which are specifically associated with t(8;21) leukemia and the prognosis of patients with this kind of abnormal karyotype is poor.
报告2例伴有t(8;21)和四倍体克隆的白血病病例。
采用R显带技术。
诊断时对骨髓细胞进行的细胞遗传学研究显示,2例病例除正常克隆外,各有3个相关异常克隆:病例1为46, XY, t(8;21) (2%)、46, 同前, add((7)(q31)(6.8%)和92, 同前x2 (80.6%);病例2为46, XX, t(8;21) (13.4%)、47, 同前, +4 (46.3%)和94, 同前x2 (39.1%)。他们化疗后未获完全缓解,分别存活4个月和6个月。
四倍体或近四倍体克隆是继发事件,与t(8;21)白血病特异性相关,具有这种异常核型的患者预后较差。